Nymox Pharmaceutical Corporation logo

Nymox Pharmaceutical Corporation

Sector: 
Healthcare
   

Industry: 
Biotechnology

0.61
 
USD
  
0.16
  
(36.44%)
Optionable: Yes  Market Cap: 37 M  90-day average vol: 492,424

Previous close: 0.45  Open: 0.45  Bid: 0.64  Ask: 0.64
52 week range    
0.19   
   2.27
Peers   
ABT / 
PFE / 
DGX / 
LLY / 
SPHS / 
Last updated: Friday 12th August 2022
50
MarketXLS Rank marketxls
40
Value marketxls
76
Technical marketxls
34
Quality marketxls

Get Access to 1 Billion Usable Market data points IN YOUR EXCEL SHEETS WITH EASY TO USE EXCEL FUNCTIONS

Get started today
Search for a stock
Are you?
twitterstocktwits
Metrics

Peers

StockDividendMarket Cap (B)PEPrice ($)

ABT

0.0147225 B32.4128.05

DGX

0.018817 B8.1132.21

JNJ

0.0247450 B22.1171.06

LLY

0.0161238 B37.4243.55

PFE

0.0302298 B15.153.21

SPHS

Chart
News
Trend Analysis & Forecast
Read more on this trend analysis & forecast here - uptrenddowntrend.com
Trendlast: -3.301


Financials

NYMX Income Statement

Annual

Dec-12Dec-13Dec-14Dec-15Dec-16Dec-17Dec-18Dec-19Dec-20Dec-21
Total revenues3 M3 M3 M3 M28400022400029900011600050000
Cost of sales243512477052167018154000170000148000135000-507000-263000-254000
Gross operating profit3 M3 M3 M3 M111000750001610005800010000
Selling Gen & administrative expense2 M2 M3 M12 M6 M5 M4 M6 M4 M6 M
Research & development expense9 M6 M5 M9 M7 M8 M7 M7 M8 M7 M
Operating income-8 M-5 M-5 M-18 M-13 M-13 M-11 M-13 M-12 M-13 M
floaterest income0000000000
floaterest expense0000000000
Other income net-28483-18195191173-46000-10000-153000-7000-12000-3000-2000
Pre-tax Income (EBT)-8 M-5 M-5 M-18 M-13 M-13 M-11 M-13 M-12 M-13 M
Income taxes00-520000000000
Net income from total operations-8 M-5 M-5 M-18 M-13 M-13 M-11 M-13 M-12 M-13 M
Minority floaterest0000000000
Total net income-8 M-5 M-5 M-18 M-13 M-13 M-11 M-13 M-12 M-13 M
Preferred dividendsN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Net income available for common-8 M-5 M-5 M-18 M-13 M-13 M-11 M-13 M-12 M-13 M
Depreciation10413910266496000300010003000565000267000254000
Amortization0000000000
Operating income before depreciation (EBITDA)-8 M-5 M-5 M-18 M-13 M-13 M-11 M-13 M-11 M-12 M
Total Income available for floaterest expense (EBIT)0000000000
Basic EPS total-0.23-0.14-0.13-0.48-0.28-0.26-0.18-0.19-0.16-0.15
Diluted EPS total-0.23-0.14-0.13-0.48-0.28-0.26-0.18-0.19-0.16-0.15
Top MarketXLS Rank stocks
Call: 1-877-778-8358Ankur Mohan
I am so happy you are here. My name is Ankur and I am the founder/CEO of MarketXLS. Over the past four years, I have helped more than 2500 customers to implement their own investment research strategies and monitoring systems in Excel.

Get Access to 1 Billion Usable Market data points IN YOUR EXCEL SHEETS WITH EASY TO USE EXCEL FUNCTIONS

Get started today

Stand with Ukraine

As the situation in Ukraine escalates, many of us in MarketXLS are left with emotions too overwhelming to name. If you’d like to show your support, but aren’t sure how to, we want to help make it easier for you to act.

For any amount donated, we’ll extend your MarketXLS subscription for double of the donated amount. Please send proof of your payment to support@marketxls.com to avail the extention

From all of us at MarketXLS, thank you!